Skip to main content
Top
Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 9/2011

01-09-2011 | Editorials

Update to readers and authors on ethical and scientific misconduct: retraction of the “Boldt articles”

Author: Donald R. Miller, MD

Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Issue 9/2011

Login to get access

Excerpt

In this issue of the Journal, most regrettably, we publish retraction notices related to five articles authored by Dr. Joachim Boldt et al. which were published during the years 2000-2003. These retraction notices refer to five of 88 articles which appear on the Editors’ Joint Statement recently posted on the websites of 18 journals, including the Canadian Journal of Anesthesia.1 This unprecedented number of simultaneous article retractions reflects more than a decade of published research examining colloid intravenous solutions and the clinical pharmacology of several anesthetic techniques and drugs used in the perioperative setting. As explained in the Editors’ Joint Statement, “the retraction of the articles in the Table for lack of Institutional Review Board (IRB) approval means that the research was unethical, and IRB approval for the research was misrepresented in the published article. It does not mean that the research results per se are fraudulent. Klinikum Ludwigshafen has commissioned an investigating committee to systematically assess the veracity of the findings presented in Dr. Boldt’s articles against patient and laboratory records. We will communicate to our readers any finding of data fabrication, falsification, or misrepresentation identified by the investigating committee at Klinikum Ludwigshafen.”1
Footnotes
1
Boldt J, Suttner S, Brosch C, et al. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Anesth Analg 2009; 109: 1752-62.
 
2
Boldt J, Suttner S, Brosch C, et al. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Anesth Analg 2009; 109: 1752-62.
 
Literature
3.
go back to reference Hoffart J, Teichmann A, Wessler I. Biomedical research in Germany: the role of ethics committee and State Medical Association (editorial). Anesth Analg 2011; 112: 501-3.PubMedCrossRef Hoffart J, Teichmann A, Wessler I. Biomedical research in Germany: the role of ethics committee and State Medical Association (editorial). Anesth Analg 2011; 112: 501-3.PubMedCrossRef
5.
go back to reference Hartog CS, Kohl M, Reinhart K. A systematic review of third generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 2011; 112: 635-45.PubMedCrossRef Hartog CS, Kohl M, Reinhart K. A systematic review of third generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 2011; 112: 635-45.PubMedCrossRef
6.
go back to reference Reinhart K, Takala J. Hydroxyethyl starches: what do we still know? Anesth Analg 2011; 112: 507-11.PubMedCrossRef Reinhart K, Takala J. Hydroxyethyl starches: what do we still know? Anesth Analg 2011; 112: 507-11.PubMedCrossRef
Metadata
Title
Update to readers and authors on ethical and scientific misconduct: retraction of the “Boldt articles”
Author
Donald R. Miller, MD
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Issue 9/2011
Print ISSN: 0832-610X
Electronic ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-011-9558-7

Other articles of this Issue 9/2011

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 9/2011 Go to the issue